Equities

Reska Biotech Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GWIN:PKC

Reska Biotech Inc

Actions
  • Price (USD)0.1761
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 04 2025 19:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Reska Biotech Inc is a company principally engaged in the provision of information technology (IT) services for the gaming industry. The Company is principally engaged in the provision of IT services, junket services for the gaming industry. The Company is engaged in the development of mobile application. In addition, the Company is engaged in the operation of land-based casinos.

  • Revenue in USD (TTM)0.00
  • Net income in USD-2.06m
  • Incorporated2010
  • Employees1.00
  • Location
    Reska Biotech IncRoom 8, 20/F, Aia TowerNo's 251A-301Avenida Commercial De MacauMACAU XXXXXMacauMAC
  • Phone+853 82942333
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Table Trac Inc11.15m1.45m19.17m38.0013.171.5612.851.720.31360.31362.402.640.83191.486.11293,417.4010.8314.7711.6317.3972.6170.3213.0215.8620.12--0.00--17.687.14-2.2714.3829.49--
Sports Entertainment Gaming Global Corp902.11k-20.83m22.40m12.00--0.1602--24.83-8.18-8.180.32337.490.0137--1.5175,175.84-31.60-50.11-71.14-77.4529.3044.73-2,309.30-448.15---90.820.1166---84.82-10.80-11.42--9.15--
VIP Play Inc27.68k-17.06m26.91m18.00------972.36-0.2341-0.23410.0004-0.46860.0046----1,537.78-285.60-229.42-----1,497.76---61,649.39-----8.96----96.24--37.86------
High Roller Technologies Inc28.04m-2.27m43.61m59.00--5.19--1.55-0.5693-0.56933.680.77661.94----475,322.00-15.69---60.20--58.92---8.09-----27.960.00---6.04---110.20------
Century Casinos Inc572.76m-108.36m44.46m3.18k------0.0776-3.54-3.5418.80-2.650.465483.0541.22180,055.60-8.25-3.31-9.60-3.7344.4547.68-17.72-6.771.390.48320.9883--4.6721.42-354.54--19.77--
Galaxy Gaming Inc30.21m-912.58k46.87m47.00----20.981.55-0.0335-0.03351.13-0.75250.8836--5.59642,667.30-2.67-3.48-3.42-4.0297.4297.24-3.02-5.70--1.761.92--14.218.30-45.34--76.59--
Reska Biotech Inc0.00-2.06m62.73m1.00---------0.0199-0.01990.00-0.00110.00-------822,180.00-115.48---157.28-------43.08---------100.00--29.07------
Canterbury Park Holding Corp59.10m-1.38m79.60m226.00--0.946231.781.35-0.2766-0.276611.6916.500.51741.0730.95261,502.70-1.217.57-1.388.6179.7278.89-2.3411.682.050.51640.001513.640.20420.7765-80.00-4.911.360.00
Full House Resorts Inc299.92m-40.13m81.63m1.69k--5.7434.470.2722-1.12-1.128.350.39340.456871.7567.69177,991.70-6.11-2.84-6.69-3.1751.9654.33-13.38-6.840.65240.06990.9711--21.1612.04-63.32--45.41--
Data as of Nov 04 2025. Currency figures normalised to Reska Biotech Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.